Windy City Media Group Frontpage News Home
CELEBRATING 28+ YEARS OF Lesbian Gay Bisexual and Transgender NEWS

Search Gay News Articles
Advanced Search
Gay News Sponsor Windy City Times 2014-12-17
Download Issue
  News Index   About WCMG    Publications    Bars & Clubs     Calendar   Videos   Advertisers    OUT! Guide    Classifieds     AIDS @ 32       Marriage
 Local | National | World | Politics | Obits | Profiles | Views | Entertainment | Theater | Dance | Music | Film | Art | Books | TV/Gossip
 Travel | History | Marriage | Youth | Trans | Lesbian | Celebrations | Food | Nightlife | Sports | Health | Real Estate | Autos | Pets | Crime

Children's book about embracing differences Children's book about

embracing differences
Craig Pomranz noticed that his godson seemed anxious one night when he ...

Browse Gay News Index   Browse Gay News Archives
  Windy City Times

Forum explores Truvada's use in fighting HIV
by Kate Sosin, Windy City Times
2011-06-22

facebook twitter pin it del.icio.us stumble upon digg google +1 reddit email


When Gladstone Institutes released evidence that Truvada, a one-a-day HIV pill, might prevent HIV in addition to treating it, the news sparked both excitement and skepticism.

The AIDS Healthcare Foundation (AHF), the largest HIV/AIDS medical provider in the country, came out against the use of Truvada for prevention, despite the fact that Gladstone's Iniciativa Profilaxis Preexposicion (iPrEx) trial showed the drugs to be more than 90-percent effective in preventing HIV in those who took it daily.

Experts on the study sat down with Feast of Fun podcasters Fausto FernĂ"s and Marc Felion at Center on Halsted June 15 to talk about what the study means and if Truvada could signal the end of the pandemic. Present were Dr. Robert Grant of Gladstone Institute, Keith Green, director of federal affairs at AIDS Foundation of Chicago, and a youth who participated in a similar study Green conducted in Chicago.

"In our wildest dreams, we did not think [Truvada] would be more than 90-percent effective in those who took it," Grant told the audience.

The findings also astounded Green, who halted Project PrEPare, a similar Chicago study, because he didn't want to continue administering placebos when he knew Truvada worked.

While the effectiveness of Truvada in preventing HIV is clear, the practicality of it remains uncertain. For one, Truvada is meant to be taken daily, which could pose a challenge to many not accustomed to the routine or whose lives don't always allow for consistency, such as youth living on the street. Additionally, Truvada is not without side effects including nausea, although that tends to go away over prolonged use, said Grant.

One barrier in getting people to use Truvada is stigma, Grant said.

"These pills, in particular, have been the one thing that folks want to avoid," he said, adding that fear surrounding HIV/AIDS contributes to fear around taking Truvada for prevention. "It strikes people as a misuse [of the drug]."

The drug could cost as much at $10,000 a year, an impossibly high price for people without insurance. In Illinois, the AIDS Drug Assistance Program (ADAP) which provides antiretrovirals to those who cannot afford them, is already cash-strapped. Truvada used for prevention could compete with Truvada treatments, creating a kind of Catch-22 for service providers who want to end the spread of HIV but also serve those who are positive already.

"We really have an ethical dilemma," Green said.

Still, many insurance companies are interested in Truvada for prevention because even with the cost of the drug, prevention is at least half the cost of treatment.

Rico, the youth who participated in Green's Chicago study on Truvada said that taking the drug made him "more considerate" of his body and protecting himself. He said that he had been hesitant to participate in the study but decided to sign up when he learned of the impact it could have on his community.

Grant and Green did acknowledge that iPrEx study had its shortcomings.

"I started to look at Dr. Grant's work, and those people didn't look like our people," Green said, adding that a low number of youth and African Americans had participated. Grant agreed and noted that their efforts would seek the expertise of Chicago service providers whose work included a diversity of clients. Still he added, the drug seemed to work equally well among people of every race.

As for AHF's critiques of using Truvada for prevention, neither Grant nor Green seemed to give them much weight.

"This is a large corporation, actually that has revenues above 300 million dollars a year, so well above my pay grade," said Grant, who went on to say that he was not certain about why AHF was working to discredit the trial results.

Truvada is awaiting FDA approval before it can be marketed for HIV prevention. Grant said that Gilead, the company that makes Truvada, will likely be hesitant to market the drug for prevention and that it will be up to AIDS service providers to make the leap in making Truvada more accessible.

For some, that leap can't come quickly enough.

"We either pay now or we pay forever," Grant said. "We have a chance now to stop this epidemic."


facebook twitter pin it del.icio.us stumble upon digg google +1 reddit email




Windy City Media Group does not approve or necessarily agree with the views posted below.
Please do not post letters to the editor here. Please also be civil in your dialogue.
If you need to be mean, just know that the longer you stay on this page, the more you help us.

AFC webinar shows other PrEP methods may join Truvada 2014-12-17
LoBianco now at Chicago House 2014-12-17
World: London mayoral candidate; UKIP situation; Jamaican pastor 2014-12-17
National: LGBT bill in Congress; trans soldiers; blood ban 2014-12-17
ASK LAMBDA LEGAL HIV status and employment discrimination 2014-12-17
Legislators to HHS: End blood donation policy, go to risk-based policy 2014-12-15
Choucair steps down as CDPH head 2014-12-11
Report: New HIV diagnoses in Chicago falling 2014-12-10
AFC document sums up PrEP costs on marketplace 2014-12-10
VIEWS World AIDS Day and my community's ongoing struggle 2014-12-10
HIV-positive beauty queen discusses journey 2014-12-09
World news: HIV poll; Disney art project; Putin's claim 2014-12-09
AFC announces 18 grant recipients 2014-12-05
Vaccinate Illinois Week: CDPH offers flu vaccine clinics 2014-12-05
Vida/SIDA marks World AIDS Day with vigil, dinner 2014-12-04
Runway show marks World AIDS Day 2014-12-04
Illinois health dept. discusses plans for PrEP assistance 2014-12-04
News: India jails trans; Obama on AIDS; 2015 aging confab here 2014-12-03
Coming up: Homeless LGBT youth panel; World AIDS Day at Center 2014-12-03
On World AIDS Day, Lambda calls for end to HIV criminalization 2014-12-02
Providers ask for public's help in restoring HIV/AIDS funds 2014-12-01
Advocates plan for local PrEP push 2014-12-01
World AIDS Day proclamation by President Obama 2014-11-28
Having HIV/AIDS: Fighting stigma 2014-11-26
Chicagoans among POZ 100 youth 2014-11-26
New study suggests gay genetic link 2014-11-26
Report: ACA has led to fewer uninsured LGBTs 2014-11-26
AFC prepares for World of Chocolate 2014-11-26
Smithsonian Channel looks at origins of AIDS Dec. 1 2014-11-25
Chicago prepares for World AIDS Day 2014-11-24
GLMA adds LGBT nurses' section 2014-11-24
Congresswoman's trans son; HRC co-founder arrested 2014-11-24
Oldest, biggest HIV/AIDS coalition wants scale-up of PrEP; AFC leads locally 2014-11-24
AFC prepares for 30th anniversary 2014-11-20
VIEWS Stigma continues with new HIV-criminalization case 2014-11-19
Gay environmentalist wants to create a 'fabulous planet' 2014-11-18
Chicagoans among POZ 100 youth 2014-11-18
New study: HIV up among Black gay men, gaps in access 2014-11-17
Blood safety panel recommends change to gay donation ban 2014-11-14
UN committee on torture concerned about LGBT conversion therapy 2014-11-13





Copyright © 2014 Windy City Media Group. All rights reserved.
Reprint by permission only. PDFs for back issues are downloadable from
the online archives. Single copies of back issues in print form are
available for $4 per issue, older than one month for $6 if available,
by check to the mailing address listed below.

Return postage must accompany all manuscripts, drawings, and
photographs submitted if they are to be returned, and no
responsibility may be assumed for unsolicited materials.
All rights to letters, art and photos sent to Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago
Gay and Lesbian News and Feature Publication) will be treated
as unconditionally assigned for publication purposes and as such,
subject to editing and comment. The opinions expressed by the
columnists, cartoonists, letter writers, and commentators are
their own and do not necessarily reflect the position of Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago Gay,
Lesbian, Bisexual and Transegender News and Feature Publication).

The appearance of a name, image or photo of a person or group in
Nightspots (Chicago GLBT Nightlife News) and Windy City Times
(a Chicago Gay, Lesbian, Bisexual and Transgender News and Feature
Publication) does not indicate the sexual orientation of such
individuals or groups. While we encourage readers to support the
advertisers who make this newspaper possible, Nightspots (Chicago
GLBT Nightlife News) and Windy City Times (a Chicago Gay, Lesbian
News and Feature Publication) cannot accept responsibility for
any advertising claims or promotions.

 

 

 



 

Myles Brady: Howard Brown's first transgender outreach coordinator
 
National: LGBT bill in Congress; trans soldiers; blood ban
 
Entertainment: 'Broadway Bares' news; Grindr awards; Robyn's new CD
 
Many GLBT homicides connected to sex work, rallies Dec. 17
 
TRAVEL Adults-only spots in Cancun
 
Windy City Times Current DownloadNightspots Current DownloadQueercast Current Download
Windy City Media Group BlogsJoin Our Email List!Donate Now








  News Index   About WCMG    Publications    Bars & Clubs     Calendar   Videos   Advertisers    OUT! Guide    Classifieds     AIDS @ 32       Marriage
 Local | National | World | Politics | Obits | Profiles | Views | Entertainment | Theater | Dance | Music | Film | Art | Books | TV/Gossip
 Travel | History | Marriage | Youth | Trans | Lesbian | Celebrations | Food | Nightlife | Sports | Health | Real Estate | Autos | Pets | Crime



About WCMG      Contact Us      Online Front  Page      Windy City  Times      Nightspots      OUT! Guide     
Identity      BLACKlines      En La Vida      Archives      Subscriptions      Distribution      Windy City Queercast     
Queercast Archives      Advertising  Rates      Deadlines      Advanced Search     
Press  Releases      Event Photos      Join WCMG  Email List      Email Blast     
Upcoming Events      Todays Events      Ongoing Events      Post an Event      Bar Guide      Community Groups      In Memoriam      Outguide Categories      Outguide Advertisers      Search Outguide      Travel      Dining Out      Blogs      Spotlight  Video      News Videos      Nightspots Videos      Entertainment Videos      Queercast Videos      Comedy Videos     
Classifieds      Real Estate      Place a  Classified     

Windy City Media Group produces Windy City Queercast, & publishes Windy City Times,
The Weekly Voice of the Gay, Lesbian, Bisexual and Trans Community,
Nightspots, Out! Resource Guide, and Identity.
5315 N. Clark St. #192, Chicago, IL 60640-2113 • PH (773) 871-7610 • FAX (773) 871-7609.